The Associate Vice Chancellor (AVC) for Innovation and Technology Commercialization fosters university-industry relationships that are integral to the growth and impact of UC Davis research. The AVC will identify current and emerging research strengths at UC Davis and establish innovative partnerships between the university and corporate partners, as an advocate for UC Davis’ intellectual property. […]
Original Post: research.ucdavis.edu/eicosis-receives-15m-to-help-fund-human-clinical-trials-of-non-opioid-pain-therapy EicOsis LLC, a UC Davis-enabled startup, announced yesterday (Oct. 15) it has been awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to support human clinical trials of a non-opioid pain therapy. The technology of the lead compounds was developed at UC Davis in the lab of Professor […]
Delix Therapeutics, founded by David Olson, an assistant professor in the Department of Chemistry and the Department of Biochemistry and Molecular Medicine, is investigating whether neural plasticity–promoting drugs can lead to new treatments for depression, anxiety and related disorders. Atrophy of neurons in the prefrontal cortex of the brain is known to play a key role in depression and […]
Syncanica Bio, a startup founded by Professor Mark Mascal with support from Ph.D. graduate Fei Chang, is investigating a synthetic cannabidiol (CBD) analogue as a novel therapeutic compound for conditions including anxiety, glaucoma and epilepsy. Products containing CBD derived from cannabis or hemp plants have become popular for their potential health effects in part because […]
The agriculture sector is facing an enormous task—to increase food production to support the planet’s explosive population growth. At the same time, the industry must address a growing number of food safety challenges associated with pathogenic bacteria like Salmonella and E. coli. These challenges are driving the need for and adoption of innovative solutions at the farm level, […]
In 2017, geneticists from UC Davis sequenced the genome of Coffea arabica —a species responsible for 70% of global coffee production—with the goal of developing new high-yielding and high-quality varieties adapted to the stresses caused by climate change. Progress from the research enabled the formation of a new company, Frinj Coffee, founded by Jay Ruskey, a farmer, and Juan […]
William (Bill) Tucker has been appointed interim associate vice chancellor for Innovation and Technology Commercialization within the UC Davis Office of Research. In his interim role, Tucker will assume responsibility of Venture Catalyst, which facilitates the creation of new ventures and technology startups enabled by university innovations. He will continue to oversee the operations of […]